- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00003519
Kombination af kemoterapi til behandling af kvinder med brystkræft
Fase III undersøgelse af Adriamycin/Taxotere versus Adriamycin/Cytoxan til adjuverende behandling af nodepositiv eller højrisikoknudenegativ brystkræft
RATIONALE: Lægemidler, der bruges i kemoterapi, bruger forskellige måder til at forhindre tumorceller i at dele sig, så de holder op med at vokse eller dør. Kombination af mere end et lægemiddel kan dræbe flere tumorceller. Det vides endnu ikke, hvilken kombination af kemoterapi, der er mest effektiv mod brystkræft.
FORMÅL: Randomiseret fase III-forsøg til at sammenligne effektiviteten af to kombinationskemoterapiregimer til behandling af kvinder med brystkræft, som har gennemgået en operation for at fjerne tumoren.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
MÅL: I. Bestem, om doxorubicin/docetaxel (DD) vil forbedre sygdomsfri overlevelse og overordnet overlevelse sammenlignet med doxorubicin/cyclophosphamid (DC) hos kvinder med lymfeknudepositive (1-3 positive noder) eller højrisiko lymfeknudenegative bryster Kræft. II. Sammenlign toksiciteten af DD til DC i denne patientpopulation.
OVERSIGT: Dette er en randomiseret undersøgelse. Patienterne er stratificeret efter nodestatus (positiv vs negativ), overgangsalderen status (før- vs post), østrogenreceptor (ER) status/progesteronreceptor (PR) status (ER/PR ukendt vs ER+/PR+ vs ER+/PR- vs ER -/PR+ vs ER-/PR-). Patienter i arm I får doxorubicin IV plus docetaxel IV over 1 time hver 3. uge i 4 behandlingsforløb. Patienter i arm II får doxorubicin IV plus cyclophosphamid IV hver 3. uge i 4 behandlingsforløb. Alle patienter, der er østrogenreceptor- eller progesteronreceptorpositive, modtager oral tamoxifen dagligt i 5 år efter kemoterapi. Nogle patienter kan også modtage strålebehandling efter kemoterapi. Patienter følges hver 3. måned, hvis patienten er mindre end 2 år fra studiestart; hver 6. måned, hvis patienten er 2-5 år fra studiestart; og hver 12. måned, hvis patienten er mere end 5 år fra studiestart.
PROJEKTERET TILSLUTNING: Ca. 2778 patienter vil blive opsamlet til denne undersøgelse inden for 2,5 år.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35233
- Veterans Affairs Medical Center - Birmingham
-
Mobile, Alabama, Forenede Stater, 36688
- MBCCOP - University of South Alabama
-
-
Arizona
-
Phoenix, Arizona, Forenede Stater, 85006-2726
- CCOP - Greater Phoenix
-
Phoenix, Arizona, Forenede Stater, 85012
- Veterans Affairs Medical Center - Phoenix (Hayden)
-
Tucson, Arizona, Forenede Stater, 85724
- Arizona Cancer Center
-
Tucson, Arizona, Forenede Stater, 85723
- Veterans Affairs Medical Center - Tucson
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater, 72205
- University of Arkansas for Medical Sciences
-
Little Rock, Arkansas, Forenede Stater, 72205
- Veterans Affairs Medical Center - Little Rock (McClellan)
-
-
California
-
Duarte, California, Forenede Stater, 91010
- Beckman Research Institute, City of Hope
-
La Jolla, California, Forenede Stater, 92093-0658
- University of California San Diego Cancer Center
-
Long Beach, California, Forenede Stater, 90822
- Veterans Affairs Medical Center - Long Beach
-
Los Angeles, California, Forenede Stater, 90033-0800
- USC/Norris Comprehensive Cancer Center
-
Los Angeles, California, Forenede Stater, 90095-1781
- Jonsson Comprehensive Cancer Center, UCLA
-
Martinez, California, Forenede Stater, 94553
- Veterans Affairs Outpatient Clinic - Martinez
-
Oakland, California, Forenede Stater, 94609-3305
- CCOP - Bay Area Tumor Institute
-
Orange, California, Forenede Stater, 92868
- Chao Family Comprehensive Cancer Center
-
Sacramento, California, Forenede Stater, 95817
- University of California Davis Medical Center
-
San Francisco, California, Forenede Stater, 94121
- Veterans Affairs Medical Center - San Francisco
-
San Francisco, California, Forenede Stater, 94115-0128
- UCSF Cancer Center and Cancer Research Institute
-
Santa Rosa, California, Forenede Stater, 95403
- CCOP - Santa Rosa Memorial Hospital
-
Travis Air Force Base, California, Forenede Stater, 94535
- David Grant Medical Center
-
Van Nuys, California, Forenede Stater, 91405
- Van Nuys Breast Center
-
-
Colorado
-
Denver, Colorado, Forenede Stater, 80220
- Veterans Affairs Medical Center - Denver
-
Denver, Colorado, Forenede Stater, 80262
- University of Colorado Cancer Center
-
-
Delaware
-
Wilmington, Delaware, Forenede Stater, 19899
- CCOP - Christiana Care Health Services
-
-
District of Columbia
-
Washington, District of Columbia, Forenede Stater, 20307-5000
- Walter Reed Army Medical Center
-
Washington, District of Columbia, Forenede Stater, 20007
- Vincent T. Lombardi Cancer Research Center, Georgetown University
-
-
Florida
-
Miami Beach, Florida, Forenede Stater, 33140
- CCOP - Mount Sinai Medical Center
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30342-1701
- CCOP - Atlanta Regional
-
Fort Gordon, Georgia, Forenede Stater, 30905-5650
- Dwight David Eisenhower Army Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, Forenede Stater, 96813
- Cancer Research Center of Hawaii
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60612
- Veterans Affairs Medical Center - Chicago (Westside Hospital)
-
Chicago, Illinois, Forenede Stater, 60637
- University of Chicago Cancer Research Center
-
Chicago, Illinois, Forenede Stater, 60612
- University of Illinois at Chicago Health Sciences Center
-
Hines, Illinois, Forenede Stater, 60141
- Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital)
-
Maywood, Illinois, Forenede Stater, 60153
- Loyola University Medical Center
-
Springfield, Illinois, Forenede Stater, 62526
- CCOP - Central Illinois
-
-
Iowa
-
Iowa City, Iowa, Forenede Stater, 52242
- University of Iowa Hospitals and Clinics
-
-
Kansas
-
Kansas City, Kansas, Forenede Stater, 66160-7357
- University Of Kansas Medical Center
-
Wichita, Kansas, Forenede Stater, 67214-3882
- CCOP - Wichita
-
Wichita, Kansas, Forenede Stater, 67218
- Veterans Affairs Medical Center - Wichita
-
-
Kentucky
-
Lexington, Kentucky, Forenede Stater, 40511-1093
- Veterans Affairs Medical Center - Lexington
-
Lexington, Kentucky, Forenede Stater, 40536-0084
- Albert B. Chandler Medical Center, University of Kentucky
-
-
Louisiana
-
New Orleans, Louisiana, Forenede Stater, 70112
- Tulane University School of Medicine
-
New Orleans, Louisiana, Forenede Stater, 70112
- MBCCOP - LSU Medical Center
-
New Orleans, Louisiana, Forenede Stater, 70112
- Veterans Affairs Medical Center - New Orleans
-
Shreveport, Louisiana, Forenede Stater, 71130
- Veterans Affairs Medical Center - Shreveport
-
Shreveport, Louisiana, Forenede Stater, 71130-3932
- Louisiana State University Hospital - Shreveport
-
-
Maine
-
Togus, Maine, Forenede Stater, 04330
- Veterans Affairs Medical Center - Togus
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21201
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02115
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, Forenede Stater, 02118
- Boston Medical Center
-
Jamaica Plain, Massachusetts, Forenede Stater, 02130
- Veterans Affairs Medical Center - Boston (Jamaica Plain)
-
Worcester, Massachusetts, Forenede Stater, 01655
- University of Massachusetts Memorial Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48109-0752
- University of Michigan Comprehensive Cancer Center
-
Ann Arbor, Michigan, Forenede Stater, 48105
- Veterans Affairs Medical Center - Ann Arbor
-
Detroit, Michigan, Forenede Stater, 48201
- Barbara Ann Karmanos Cancer Institute
-
Detroit, Michigan, Forenede Stater, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Forenede Stater, 48201-1932
- Veterans Affairs Medical Center - Detroit
-
Grand Rapids, Michigan, Forenede Stater, 49503
- CCOP - Grand Rapids Clinical Oncology Program
-
Southfield, Michigan, Forenede Stater, 48075-9975
- Providence Hospital - Southfield
-
-
Minnesota
-
Minneapolis, Minnesota, Forenede Stater, 55417
- Veterans Affairs Medical Center - Minneapolis
-
Minneapolis, Minnesota, Forenede Stater, 55455
- University of Minnesota Cancer Center
-
-
Mississippi
-
Biloxi, Mississippi, Forenede Stater, 39531-2410
- Veterans Affairs Medical Center - Biloxi
-
Jackson, Mississippi, Forenede Stater, 39216-4505
- University of Mississippi Medical Center
-
Jackson, Mississippi, Forenede Stater, 39216
- Veterans Affairs Medical Center - Jackson
-
Keesler Air Force Base, Mississippi, Forenede Stater, 39534-2576
- Keesler Medical Center - Keesler AFB
-
-
Missouri
-
Columbia, Missouri, Forenede Stater, 65201
- Veterans Affairs Medical Center - Columbia (Truman Memorial)
-
Columbia, Missouri, Forenede Stater, 65203
- Ellis Fischel Cancer Center - Columbia
-
Kansas City, Missouri, Forenede Stater, 64128
- Veterans Affairs Medical Center - Kansas City
-
Kansas City, Missouri, Forenede Stater, 64131
- CCOP - Kansas City
-
Saint Louis, Missouri, Forenede Stater, 63110
- Barnes-Jewish Hospital
-
Saint Louis, Missouri, Forenede Stater, 63110-0250
- St. Louis University Health Sciences Center
-
Saint Louis, Missouri, Forenede Stater, 63141
- CCOP - St. Louis-Cape Girardeau
-
Springfield, Missouri, Forenede Stater, 65807
- CCOP - Ozarks Regional
-
-
Montana
-
Billings, Montana, Forenede Stater, 59101
- CCOP - Montana Cancer Consortium
-
-
Nebraska
-
Omaha, Nebraska, Forenede Stater, 68198-3330
- University of Nebraska Medical Center
-
Omaha, Nebraska, Forenede Stater, 68105
- Veterans Affairs Medical Center - Omaha
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89106
- CCOP - Southern Nevada Cancer Research Foundation
-
-
New Hampshire
-
Lebanon, New Hampshire, Forenede Stater, 03756
- Norris Cotton Cancer Center
-
-
New Mexico
-
Albuquerque, New Mexico, Forenede Stater, 87108-5138
- Veterans Affairs Medical Center - Albuquerque
-
Albuquerque, New Mexico, Forenede Stater, 87131
- University of New Mexico Cancer Research & Treatment Center
-
-
New York
-
Brooklyn, New York, Forenede Stater, 11209
- Veterans Affairs Medical Center - Brooklyn
-
Buffalo, New York, Forenede Stater, 14263-0001
- Roswell Park Cancer Institute
-
Buffalo, New York, Forenede Stater, 14215
- Veterans Affairs Medical Center - Buffalo
-
Manhasset, New York, Forenede Stater, 11030
- CCOP - North Shore University Hospital
-
Manhasset, New York, Forenede Stater, 11030
- North Shore University Hospital
-
New York, New York, Forenede Stater, 10021
- Memorial Sloan-Kettering Cancer Center
-
New York, New York, Forenede Stater, 10021
- New York Presbyterian Hospital - Cornell Campus
-
New York, New York, Forenede Stater, 10029
- Mount Sinai Medical Center, NY
-
New York, New York, Forenede Stater, 10032
- Herbert Irving Comprehensive Cancer Center
-
Syracuse, New York, Forenede Stater, 13210
- State University of New York - Upstate Medical University
-
Syracuse, New York, Forenede Stater, 13210
- Veterans Affairs Medical Center - Syracuse
-
Syracuse, New York, Forenede Stater, 13210
- CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
-
-
North Carolina
-
Chapel Hill, North Carolina, Forenede Stater, 27599-7295
- Lineberger Comprehensive Cancer Center, UNC
-
Durham, North Carolina, Forenede Stater, 27705
- Veterans Affairs Medical Center - Durham
-
Durham, North Carolina, Forenede Stater, 27710
- Duke Comprehensive Cancer Center
-
Winston-Salem, North Carolina, Forenede Stater, 27104-4241
- CCOP - Southeast Cancer Control Consortium
-
Winston-Salem, North Carolina, Forenede Stater, 27157-1082
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
-
-
Ohio
-
Cincinnati, Ohio, Forenede Stater, 45219
- Barrett Cancer Center, The University Hospital
-
Cincinnati, Ohio, Forenede Stater, 45220-2288
- Veterans Affairs Medical Center - Cincinnati
-
Cleveland, Ohio, Forenede Stater, 44195
- Cleveland Clinic Cancer Center
-
Columbus, Ohio, Forenede Stater, 43206
- CCOP - Columbus
-
Columbus, Ohio, Forenede Stater, 43210
- Arthur G. James Cancer Hospital - Ohio State University
-
Dayton, Ohio, Forenede Stater, 45428
- Veterans Affairs Medical Center - Dayton
-
Kettering, Ohio, Forenede Stater, 45429
- CCOP - Dayton
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73104
- Oklahoma Medical Research Foundation
-
Oklahoma City, Oklahoma, Forenede Stater, 73104
- Veterans Affairs Medical Center - Oklahoma City
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97201-3098
- Oregon Cancer Center at Oregon Health Sciences University
-
Portland, Oregon, Forenede Stater, 97207
- Veterans Affairs Medical Center - Portland
-
Portland, Oregon, Forenede Stater, 97213
- CCOP - Columbia River Program
-
-
Rhode Island
-
Providence, Rhode Island, Forenede Stater, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Charleston, South Carolina, Forenede Stater, 29425-0721
- Medical University of South Carolina
-
Greenville, South Carolina, Forenede Stater, 29615
- CCOP - Greenville
-
Spartanburg, South Carolina, Forenede Stater, 29303
- CCOP - Upstate Carolina
-
-
Tennessee
-
Memphis, Tennessee, Forenede Stater, 38104
- Veterans Affairs Medical Center - Memphis
-
Memphis, Tennessee, Forenede Stater, 38163
- University of Tennessee, Memphis Cancer Center
-
-
Texas
-
Fort Sam Houston, Texas, Forenede Stater, 78234
- Brooke Army Medical Center
-
Galveston, Texas, Forenede Stater, 77555-1329
- University of Texas Medical Branch
-
Lubbock, Texas, Forenede Stater, 79423
- Texas Tech University Health Science Center
-
San Antonio, Texas, Forenede Stater, 78284
- Veterans Affairs Medical Center - San Antonio (Murphy)
-
San Antonio, Texas, Forenede Stater, 78284
- University of Texas Health Science Center at San Antonio
-
Temple, Texas, Forenede Stater, 76504
- Veterans Affairs Medical Center - Temple
-
Temple, Texas, Forenede Stater, 76508
- CCOP - Scott and White Hospital
-
-
Utah
-
Salt Lake City, Utah, Forenede Stater, 84132
- Huntsman Cancer Institute
-
Salt Lake City, Utah, Forenede Stater, 84148
- Veterans Affairs Medical Center - Salt Lake City
-
-
Vermont
-
Burlington, Vermont, Forenede Stater, 05401-3498
- Vermont Cancer Center
-
White River Junction, Vermont, Forenede Stater, 05009
- Veterans Affairs Medical Center - White River Junction
-
-
Virginia
-
Richmond, Virginia, Forenede Stater, 23298-0037
- MBCCOP - Massey Cancer Center
-
Richmond, Virginia, Forenede Stater, 23249
- Veterans Affairs Medical Center - Richmond
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98101
- CCOP - Virginia Mason Research Center
-
Seattle, Washington, Forenede Stater, 98108
- Veterans Affairs Medical Center - Seattle
-
Seattle, Washington, Forenede Stater, 98104
- Swedish Hospital Tumor Institute
-
Tacoma, Washington, Forenede Stater, 98405-0986
- CCOP - Northwest
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Beskrivelse
SYGDOMSKARAKTERISTIKA: Histologisk bekræftet resektabelt adenokarcinom i brystet Histologisk positive lymfeknuder (1 til 3) ELLER Lymfeknude-negativ og højrisikosygdom Tumor større end 1,0 cm diameter Kan have gennemgået en aksillær dissektion med mindst 6 noder fjernet og undersøgt eller en vagtpost nodebiopsi Patienter, der er positive ved sentinel node biopsi, vil modtage en aksillær dissektion Ingen lokalt fremskreden eller inflammatorisk eller metastatisk brystkræft Hormonreceptorstatus: Ikke specificeret
PATIENT KARAKTERISTIKA: Alder: 18 og derover Køn: Kvinde Menopausal status: Ikke specificeret Ydeevnestatus: Ikke specificeret Forventet levetid: Ikke specificeret Hæmatopoietisk: Neutrofiltal mindst 1.500/mm3 Trombocyttal mindst 100.000/mm3 Lever: Tilstrækkelig leverfunktion Bilirubin end øvre normalgrænse Nyre: Tilstrækkelig nyrefunktion Kardiovaskulær: Tilstrækkelig hjertefunktion Normal MUGA eller ekkokardiogram Andet: Ikke gravid eller ammende Fertile patienter skal bruge effektiv barrieremetode prævention Mindst 5 år siden tidligere invasive maligniteter, undtagen basalcelle- eller pladecellekarcinom af huden eller carcinom in situ af livmoderhalsen
TIDLIGERE SAMTYDLIG BEHANDLING: Biologisk behandling: Ikke specificeret Kemoterapi: Ingen forudgående kemoterapi for denne malignitet Endokrin behandling: Ingen samtidig tamoxifen Op til 4 ugers tamoxifenbehandling for denne malignitet tilladt Strålebehandling: Ingen forudgående strålebehandling for denne malignitet Forudgående strålebehandling til brystet for duktalt karcinom in situ tilladt Kirurgi: Tumor bør fjernes ved enten en modificeret radikal mastektomi og/eller en segmental mastektomi plus aksillær lymfeknudedissektion eller sentinel node biopsi før påbegyndelse af behandling efter protokol Ikke mere end 84 dage siden sidste kirurgiske procedure, der udgør eller fuldender endelig kirurgisk indgreb terapi (mastektomi; aksillær dissektion/sentinel node biopsi; eller resektion af primært sted for at opnå en negativ margin
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Studiestol: Lori J. Goldstein, MD, Fox Chase Cancer Center
- Studiestol: Silvana Martino, DO, Van Nuys Breast Center
- Studiestol: Larry Norton, MD, Memorial Sloan Kettering Cancer Center
- Studiestol: Edith A. Perez, MD, Mayo Clinic
Publikationer og nyttige links
Generelle publikationer
- Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol. 2008 May 20;26(15):2473-81. doi: 10.1200/JCO.2007.13.6424. Erratum In: J Clin Oncol. 2008 Jul 10;26(20):3472. Perez, Edith D [corrected to Perez, Edith A].
- Goldstein LJ, Gray R, Badve S, Childs BH, Yoshizawa C, Rowley S, Shak S, Baehner FL, Ravdin PM, Davidson NE, Sledge GW Jr, Perez EA, Shulman LN, Martino S, Sparano JA. Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol. 2008 Sep 1;26(25):4063-71. doi: 10.1200/JCO.2007.14.4501. Epub 2008 Aug 4. Erratum In: J Clin Oncol. 2009 Jul 20;27(21):3566.
- Goldstein LJ, Gray R, Childs BH, et al.: Prognostic utility of 21-gene assay in hormone receptor (HR) positive operable breast cancer and 0-3 positive axillary nodes treated with adjuvant chemohormonal therapy (CHT): an analysis of Intergroup trial E2197. [Abstract] J Clin Oncol 25 (Suppl 18): A-526, 2007.
- Goldstein LJ, O'Neill A, Sparano J, et al.: E2197: Phase III AT (doxorubucin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer. [Abstract] J Clin Oncol 23 (Suppl 16): A-512, 7s, 2005.
- Goldstein LJ, O'Neill A, Sparano JA, et al.: LVEF assessment of adjuvant doxorubicin/cyclophosphamide (AC) vs. doxorubicin/docetaxel (AT) in early stage breast cancer: cardiac safety results of ECOG 2197. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-73, 2003.
- Goldstein L, Ravdin P, Gray R, et al.: Prognostic utility of the 21-gene assay compared with adjuvant in hormone receptor (HR) positive operable breast cancer with 0-3 positive axillary nodes treated with adjuvant chemohormonal therapy (CHT): an analysis of intergroup trial E2197. [Abstract] Breast Cancer Res Treat 106 (1): A-63, S17, 2007.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Anslået)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Hudsygdomme
- Neoplasmer
- Neoplasmer efter sted
- Brystsygdomme
- Brystneoplasmer
- Lægemidlers fysiologiske virkninger
- Molekylære mekanismer for farmakologisk virkning
- Enzymhæmmere
- Antirheumatiske midler
- Antineoplastiske midler
- Immunsuppressive midler
- Immunologiske faktorer
- Tubulin modulatorer
- Antimitotiske midler
- Mitose modulatorer
- Antineoplastiske midler, Alkylering
- Alkyleringsmidler
- Myeloablative agonister
- Topoisomerase II-hæmmere
- Topoisomerasehæmmere
- Antibiotika, antineoplastisk
- Docetaxel
- Cyclofosfamid
- Doxorubicin
- Liposomal doxorubicin
Andre undersøgelses-id-numre
- CDR0000066563
- E2197
- CLB-49802
- NCCTG-E2197
- SWOG-E2197
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Brystkræft
-
Cairo UniversityIkke rekrutterer endnu
-
Abouqir General HospitalAlexandria UniversityRekrutteringBreast Udseende Rekonstruktion DisproportionEgypten
-
The First Affiliated Hospital of Xiamen UniversityIkke rekrutterer endnuLocally Advanced Breast Cancer (LABC)
-
Beijing Bio-Targeting Therapeutics Technology Co...Trukket tilbage
-
Indonesia UniversityIkke rekrutterer endnuPræhabilitering | Postoperativ inflammation | Locally Advanced Breast Cancer (LABC)Indonesien
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbejdspartnereAfsluttetDen kliniske anvendelsesvejledning af Conebeam Breast CTKina
-
Atlas UniversityIkke rekrutterer endnuBrystkræft | Locally Advanced Breast Cancer (LABC)Tyrkiet (Türkiye)
-
ETOP IBCSG Partners FoundationAfsluttetBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAfsluttetBreast Cancer Invasive NosSpanien
-
Second Affiliated Hospital, School of Medicine,...RekrutteringTNBC, Triple Negative Breast CancerKina
Kliniske forsøg med cyclophosphamid
-
University of Colorado, DenverAfsluttetAkut myeloid leukæmi | Recidiverende/Refraktær Akut Myeloid LeukæmiForenede Stater
-
Children's Hospital Los AngelesLucile Packard Children's HospitalAfsluttetMetaboliske sygdomme | Stamcelletransplantation | Kronisk granulomatøs sygdom | Knoglemarvstransplantation | Thalassæmi | Wiskott-Aldrich syndrom | Genetiske sygdomme | Perifer blodstamcelletransplantation | Pædiatri | Diamond-Blackfan Anæmi | Allogen Transplantation | Kombineret immundefekt | X-bundet lymfoproliferativ...
-
TCRCure Biopharma Ltd.Rekruttering
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... og andre samarbejdspartnereAfsluttetAnæmi, aplastiskForenede Stater
-
Second Affiliated Hospital, School of Medicine,...Ikke rekrutterer endnuLivmoderhalskræft | Primær peritoneal kræft | Æggelederkræft
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI Breast Cancer Research Group og andre samarbejdspartnereAktiv, ikke rekrutterendeBrystkræft fase II | Brystkræft fase IIISpanien, Frankrig, Italien, Belgien, Jordan, Polen, Tyskland, Det Forenede Kongerige, Portugal
-
Institut BergoniéMerck Sharp & Dohme LLC; National Cancer Institute, France; Transgene; Fondation...RekrutteringBrystkræft | Blødt væv sarkom | Faste tumorerFrankrig
-
Mahidol UniversityAfsluttetNyreinsufficiens | InfektionThailand
-
Shandong Cancer Hospital and InstituteUkendt
-
National Cancer Institute, NaplesImmatics Biotechnologies GmbH; CureVac; European Commission -FP7-Health-2013-Innovation-1AfsluttetHepatocellulært karcinomBelgien, Tyskland, Italien, Spanien, Det Forenede Kongerige